Screening for esophageal involvement in morphea: Is it needed?
References
Arif T, Adil M, Amin SS, Tahseen M, Dorjay K, Mohtashim M et al. Clinico-epidemiological Study of Morphea from a Tertiary Care Hospital. Curr Rheumatol Rev. 2018;14:251-4..
Arif T, Massod Q, Singh J, Hassan I. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study. BMC Gastroenterol. 2015;15:24.
Zaninotto G, Peserico A, Costantini M, Salvador L, Rondinone R. Oesophageal motility and lower oesophageal sphincter competence in progressive systemic sclerosis and localized scleroderma. Scand J Gastroenterol. 1989;24:95-102.
Weihrauch TR, Korting GW. Manometric assessment of esophageal involvement in progressive systemic sclerosis, morphoea and Raynaud’s disease. Br J Dermatol. 1982;107:325-32.
Dehen L, Roujeau JC, Cosnes A, Revuz J. Internal involvement in localized scleroderma. Medicine. 1994;73:241-5.
Callen JP. Esophageal Involvement Is Not Seen in Patients with Morphea (Localized Scleroderma). NEJM Journal Watch. September 29, 2015. Available at https://www.jwatch.org/na39063/2015/09/29/esophageal-involvement-not-seen-patients-with-morphea
Guariso G, Conte S, Galeazzi F, Vettorato MG, Martini G, Zulian F. Esophageal involvement in juvenile localized scleroderma: a pilot study. Clin Exp Rheumatol. 2007;25:786-9.
Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005;52:2873-81.
